119 related articles for article (PubMed ID: 18504133)
1. Hybrids of 1-deoxynojirimycin and aryl-1,2,3-triazoles and biological studies related to angiogenesis.
Zhao Y; Zhou Y; O'Boyle KM; Murphy PV
Bioorg Med Chem; 2008 Jun; 16(12):6333-7. PubMed ID: 18504133
[TBL] [Abstract][Full Text] [Related]
2. Biological study of the angiogenesis inhibitor N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin.
Zhao Y; Zhou Y; O' Boyle KM; Murphy PV
Chem Biol Drug Des; 2010 Jun; 75(6):570-7. PubMed ID: 20565474
[TBL] [Abstract][Full Text] [Related]
3. Hybrid angiogenesis inhibitors: synthesis and biological evaluation of bifunctional compounds based on 1-deoxynojirimycin and aryl-1,2,3-triazoles.
Zhou Y; Zhao Y; O' Boyle KM; Murphy PV
Bioorg Med Chem Lett; 2008 Feb; 18(3):954-8. PubMed ID: 18166456
[TBL] [Abstract][Full Text] [Related]
4. 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.
Kallander LS; Lu Q; Chen W; Tomaszek T; Yang G; Tew D; Meek TD; Hofmann GA; Schulz-Pritchard CK; Smith WW; Janson CA; Ryan MD; Zhang GF; Johanson KO; Kirkpatrick RB; Ho TF; Fisher PW; Mattern MR; Johnson RK; Hansbury MJ; Winkler JD; Ward KW; Veber DF; Thompson SK
J Med Chem; 2005 Sep; 48(18):5644-7. PubMed ID: 16134930
[TBL] [Abstract][Full Text] [Related]
5. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
Marino JP; Fisher PW; Hofmann GA; Kirkpatrick RB; Janson CA; Johnson RK; Ma C; Mattern M; Meek TD; Ryan MD; Schulz C; Smith WW; Tew DG; Tomazek TA; Veber DF; Xiong WC; Yamamoto Y; Yamashita K; Yang G; Thompson SK
J Med Chem; 2007 Aug; 50(16):3777-85. PubMed ID: 17636946
[TBL] [Abstract][Full Text] [Related]
6. Biological study of a somatostatin mimetic based on the 1-deoxynojrimycin scaffold.
Zhao Y; Liu M; Chagnault V; Wang J; Zhang X; Murphy PV
Bioorg Med Chem Lett; 2011 Jan; 21(2):824-8. PubMed ID: 21194941
[TBL] [Abstract][Full Text] [Related]
7. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
Lu J; Chong CR; Hu X; Liu JO
J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
Rawlings AJ; Lomas H; Pilling AW; Lee MJ; Alonzi DS; Rountree JS; Jenkinson SF; Fleet GW; Dwek RA; Jones JH; Butters TD
Chembiochem; 2009 Apr; 10(6):1101-5. PubMed ID: 19294724
[TBL] [Abstract][Full Text] [Related]
9. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
Zhou G; Tsai CW; Liu JO
J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
[TBL] [Abstract][Full Text] [Related]
10. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
11. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
Wang J; Lou P; Henkin J
J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cells with the angiogenic inhibitor fumagillin results in increased stability of eukaryotic initiation factor 2-associated glycoprotein, p67, and reduced phosphorylation of extracellular signal-regulated kinases.
Datta B; Majumdar A; Datta R; Balusu R
Biochemistry; 2004 Nov; 43(46):14821-31. PubMed ID: 15544353
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
Ding SZ; Smith MF; Goldberg JB
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2).
Garrabrant T; Tuman RW; Ludovici D; Tominovich R; Simoneaux RL; Galemmo RA; Johnson DL
Angiogenesis; 2004; 7(2):91-6. PubMed ID: 15516829
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
McGonigle JS; Giachelli CM; Scatena M
Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
[TBL] [Abstract][Full Text] [Related]
17. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
18. Biological properties of D- and L-1-deoxyazasugars.
Kato A; Kato N; Kano E; Adachi I; Ikeda K; Yu L; Okamoto T; Banba Y; Ouchi H; Takahata H; Asano N
J Med Chem; 2005 Mar; 48(6):2036-44. PubMed ID: 15771446
[TBL] [Abstract][Full Text] [Related]
19. N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin suppresses growth and migration of human lung cancer cells.
Zhao Y; Liu W; Zhou Y; Zhang X; Murphy PV
Bioorg Med Chem Lett; 2010 Dec; 20(24):7540-3. PubMed ID: 21036045
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression.
Hu X; Addlagatta A; Lu J; Matthews BW; Liu JO
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18148-53. PubMed ID: 17114291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
